Wittmann, Stefanie
Jorgensen, Rikke
Oostenbrink, Rianne
Moll, Henriette
Herberg, Jethro
Levin, Mike
Maconochie, Ian
Nijman, Ruud
Funding for this research was provided by:
Thrasher Research Fund (Award number 12830)
NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research (ACF-2015-21-016 and CL-2018-21-007)
Article History
Received: 13 January 2023
Revised: 9 February 2023
Accepted: 16 February 2023
First Online: 3 March 2023
Declarations
:
: This study was in line with the principles of the Declaration of Helsinki. The study was part of a larger biomarker study, and approval was granted by the local Medical Ethics Committee Camden & Islington, London (Local approval number <i>14/LO/0266</i>).
: Informed consent was obtained for children included in the embedded biomarker study. A waiver of informed consent was obtained from the local Medical Ethics Committee Camden & Islington, London (Local approval number <i>14/LO/0266</i>), for this section of the ICED study as only routine clinical data were used.
: The authors declare no competing interests.